Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Edward J. Usherwood is active.

Publication


Featured researches published by Edward J. Usherwood.


Journal of General Virology | 1996

Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice

Edward J. Usherwood; James P. Stewart; Kevin Robertson; Deborah J. Allen; Anthony Nash

Murine gammaherpesvirus 68 (MHV-68) is a natural pathogen of mice which causes an acute lung infection and establishes a latent infection in B lymphocytes. In this paper we describe the infection in transgenic B cell-deficient (muMT) mice, to determine whether a latent infection can be established in a mouse lacking circulating B lymphocytes. Little difference was observed in the acute lung infection, although there was a slight delay in virus clearance in the muMT mice. This indicates that antiviral antibody is of little importance in the resolution of the lung infection. Neither free nor latent virus could be detected in the spleen in the muMT mice. In addition, these mice did not develop MHV-68-induced splenomegaly. These data suggest that within the lymphoid compartment B lymphocytes are the sole reservoir for MHV-68 infection in vivo, confirming earlier work which identified B cells as the site of latent infection based on cell fractionation studies. In addition, our study shows that CD4-driven lymphocyte expansion leading to splenomegaly is dependent on the presence of MHV-68-infected B cells in the spleen. Although no free virus was detected (using conventional biological assays) in the lung after the resolution of the acute infection, MHV-68 genome was detected in the lungs of both control and muMT mice by PCR analysis. This suggests that cells in the lung may act as a reservoir of latent virus which is independent of the B lymphocyte infection.


Journal of General Virology | 1996

Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells

Edward J. Usherwood; Alan J. Ross; Deborah J. Allen; Anthony Nash

Murine gammaherpesvirus (MHV-68) causes an acute respiratory infection followed by a latent infection in B lymphocytes. In the first 2-3 weeks after infection mice develop a marked splenomegaly, where the spleen cell number increases by 2-3 fold. Cytofluorimetric analysis during splenomegaly revealed an increase in numbers of B lymphocytes and of both CD4+ and CD8+ T lymphocytes. The largest increase relative to uninfected spleens was in the CD8+ population. The number of latently infected cells in the spleen peaked at day 10 post-intraperitoneal infection, then declined to 1/10(6)-1/10(7) cells per spleen. Depletion of CD4+ T lymphocytes prevented the splenomegaly and greatly reduced the peak infective centre level, while having no effect on the long-term of latently infected cells. Given the similarity between MHV-68-induced splenomegaly and Epstein-Barr virus-induced infectious mononucleosis, these data highlight the usefulness of MHV-68 as a mouse model for the study of gammaherpesvirus immunology and pathobiology.


Vaccine | 1999

Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: A model system for gamma-herpesvirus vaccination

James P. Stewart; Nadia Micali; Edward J. Usherwood; L Bonina; Anthony Nash

Murine gamma-herpesvirus 68 (MHV-68) is a model for the study of the pathogenesis of gamma-herpesviruses. Epstein-Barr virus (EBV) is a highly related gamma-herpesvirus that causes significant disease in humans. The major membrane antigen gp350 of EBV is a candidate vaccine antigen for protection against EBV-related disease. An MHV-68 glycoprotein, gp150, has significant homology to EBV gp350. We have therefore used the MHV-68 gp150 to model the potential efficacy of EBV gp350 in protecting from virus-associated disease. A recombinant vaccinia virus expressing MHV-68 gp150 was constructed. This recombinant vaccinia virus was used to infect mice via the subcutaneous route. This vaccination resulted in production of MHV-68-neutralising antibodies. Mice were then challenged intra-nasally with MHV-68. MHV-68-associated mononucleosis was virtually abrogated in immunised mice. However, mice did establish MHV-68 latency. The results suggest that gp350 may be effective as an immunogen to prevent EBV-associated infectious mononucleosis in humans that are EBV-seronegative.


Journal of General Virology | 1997

IMMUNOLOGICAL CONTROL OF MURINE GAMMAHERPESVIRUS INFECTION IS INDEPENDENT OF PERFORIN

Edward J. Usherwood; James W. Brooks; Sally R. Sarawar; Rhonda D. Cardin; William D. Young; Deborah J. Allen; Peter C. Doherty; Anthony Nash

Perforin-mediated cytotoxic T cell killing has been suggested to be of importance in the control of noncytopathic virus infections, based on studies with lymphocytic choriomeningitis virus (LCMV). We examined the role of perforin in a mouse model of gammaherpesvirus infection using transgenic perforin-deficient mice. Previous work from this laboratory has shown that CD8 T cells are essential for the resolution of the acute lung infection and control of latently infected B cells in murine gamma-herpesvirus 68 infection. The absence of perforin did not significantly affect the kinetics of either the lytic lung infection or the latent spleen infection. Lymphocytes from both perforin-deficient and control mice secreted comparable levels of IFN-gamma, IL-10 and IL-6. In addition, lymphocytes from both strains had similar levels of CD3epsilon-dependent cytotoxic activity in the spleen, draining lymph nodes and bronchoalveolar lavage. These data indicate that the lack of perforin has little affect on the ability of mice to control an experimental gammaherpesvirus infection.


Journal of Neuroimmunology | 1997

Characterisation of the immune response in a neural xenograft rejection paradigm

T M Litchfield; S J Whiteley; K T Yee; P Tyers; Edward J. Usherwood; Anthony Nash; R D Lund

We have looked at both donor and host MHC expression in a neural xenograft rejection paradigm. Grafts of either mouse corpus callosum or an SV40 large T transformed astrocytic cell line were placed in the mid-brain of neonatal rats. Three weeks later graft rejection was induced by the application of a skin graft of the same donor origin. MHC expression in the neural graft and the host brain was examined histologically four and ten days after the animals had received a skin graft. Donor MHC expression was detected in the corpus callosal grafts at both time points and preceded host MHC expression and the lymphocytic infiltrate. The grafts of the transformed cell line could not be induced to express MHC antigens under the experimental protocol used nor were they rejected. The migratory patterns of the transformed cells were compared to the well characterised migration patterns of astrocytes from the corpus callosal grafts.


Immunology | 1997

Immune response to murine cell lines of glial origin transplanted into the central nervous system of adult mice

L A Terry; Edward J. Usherwood; S Lees; Neil Macintyre; Anthony Nash

Temperature‐sensitive simian virus 40 (SV40) T antigen‐transformed central nervous system (CNS)‐derived murine cell lines were used to analyse the host response to transplantation in the mouse adult brain. The cell lines were shown to be susceptible to immune recognition in vitro by cytotoxic effector cells indicating that tissue‐specific privilege was not in operation. Histological examination at time points post‐implantation showed characteristic responses similar to those seen during graft rejection. Astrocytosis and up‐regulation of major histocompatibility complex (MHC) class I and MHC class II activation of resident microglia and recruitment of macrophages were observed in both allogeneic and syngeneic hosts 10 days post‐implantation suggesting a trauma‐induced response. However, the response in allogeneic hosts was more widespread and evident when the syngeneic responses had returned to normal levels. Evidence of T‐cell infiltration was also more pronounced in the allogeneic hosts. Despite quite extensive host reactions to these cellular grafts at early time‐points the implants appeared to survive in the host CNS long after the responses had abated and could be detected at the maximum time‐point studied of 40 days.


Journal of Experimental Medicine | 1998

Lung Epithelial Cells Are a Major Site of Murine Gammaherpesvirus Persistence

James P. Stewart; Edward J. Usherwood; Alan J. Ross; Heather Dyson; Tony Nash


Journal of Virology | 1996

Characterization of tumor cell lines derived from murine gammaherpesvirus-68-infected mice

Edward J. Usherwood; James P. Stewart; Anthony Nash


Journal of Experimental Medicine | 2000

Control of Gammaherpesvirus Latency by Latent Antigen-Specific Cd8+ T Cells

Edward J. Usherwood; Douglas Roy; Kim Ward; Sherri Surman; Bernadette M. Dutia; Marcia A. Blackman; James P. Stewart; David L. Woodland


Seminars in Virology | 1996

Immunological features of murine gammaherpesvirus infection

Anthony Nash; Edward J. Usherwood; James P. Stewart

Collaboration


Dive into the Edward J. Usherwood's collaboration.

Top Co-Authors

Avatar

Anthony Nash

University of Edinburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alan J. Ross

University of Edinburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Douglas Roy

University of Edinburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

L A Terry

University of Edinburgh

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge